Literature DB >> 2766759

Incidence and etiology of pneumonia acquired during mechanical ventilation.

P Jiménez1, A Torres, R Rodríguez-Roisin, J P de la Bellacasa, R Aznar, J M Gatell, A Agustí-Vidal.   

Abstract

A total of 77 consecutive patients submitted to mechanical ventilation (MV) for greater than 48 h in a respiratory ICU (RICU) were studied to investigate the incidence, etiology, and consequences of ventilator-associated pneumonia. Eighteen (23%) patients developed a bacterial pneumonia after 5.6 +/- 1.0 days (mean +/- SEM; range 2 to 17) of MV. Three additional cases were demonstrated at autopsy, raising the incidence to 27%. Overall, the mean duration of MV increased from 9.7 +/- 0.9 to 32.2 +/- 5.1 days (p less than .0001) when pneumonia developed. A longer period of hospital stay before RICU admission and the presence of chronic obstructive pulmonary disease were significant characteristics of patients with pneumonia when compared to patients without nosocomial pulmonary infection. One or more etiological agents were identified in 14 patients from the pneumonia group by means of a highly specific technique (protected brush catheter, transthoracic needle aspiration, pleural fluid, and/or blood cultures). The predominant pathogens isolated were Gram-negative bacilli (Acinetobacter sp. and Pseudomonas sp.). Half of the cases were polymicrobial. Compared to other series, our results may reflect with more accuracy the actual incidence of nosocomial pneumonia in mechanically ventilated patients, since we used highly accurate techniques along with autopsy findings which allowed us to confirm or discard the diagnosis of bacterial pneumonia.

Entities:  

Mesh:

Year:  1989        PMID: 2766759     DOI: 10.1097/00003246-198909000-00007

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  27 in total

1.  Community-acquired Acinetobacter baumannii bacteremia in adult patients in Taiwan.

Authors:  Jann-Tay Wang; Lawrence Clifford McDonald; Shan-Chwen Chang; Monto Ho
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 2.  Nosocomial pneumonia: epidemiology and infection control.

Authors:  D E Craven; K A Steger; L M Barat; R A Duncan
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 3.  Evaluation of the available invasive and non-invasive techniques for diagnosing nosocomial pneumonias in mechanically ventilated patients.

Authors:  A Torres; J González; M Ferrer
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

4.  Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis.

Authors:  P Mahul; C Auboyer; R Jospe; A Ros; C Guerin; Z el Khouri; M Galliez; A Dumont; O Gaudin
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 5.  Acinetobacter species as nosocomial pathogens.

Authors:  D H Forster; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

6.  Amikacin-fosfomycin at a five-to-two ratio: characterization of mutation rates in microbial strains causing ventilator-associated pneumonia and interactions with commonly used antibiotics.

Authors:  A Bruce Montgomery; Paul R Rhomberg; Tammy Abuan; Kathie-Anne Walters; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

Review 7.  Epidemiology, therapy and costs of nosocomial infection.

Authors:  R Gálvez-Vargas; A Bueno-Cavanillas; M García-Martín
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

8.  Impact of Candida species on clinical outcomes in patients with suspected ventilator-associated pneumonia.

Authors:  Marie-Soleil Delisle; David R Williamson; Martin Albert; Marc M Perreault; Xuran Jiang; Andrew G Day; Daren K Heyland
Journal:  Can Respir J       Date:  2011 May-Jun       Impact factor: 2.409

9.  Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia.

Authors:  S Chevret; M Hemmer; J Carlet; M Langer
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 10.  Acinetobacter infections: a growing threat for critically ill patients.

Authors:  M E Falagas; E A Karveli; I I Siempos; K Z Vardakas
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.